AGY Celiac 圖標

1.0.0 by mmHg Inc.


2021年01月28日

關於AGY Celiac

中文(繁體)

我們創建了這個應用程序來支持我們的研究。

This app is only available to those who are participating in the trial.

We have learned that we can vaccinate chickens with gluten, so that the yolks of their eggs contain an antibody against gluten, called AGY. The eggs are collected and the yolks are dried and put into capsules. A type of sugar, mannitol, is also added to the capsule to help protect the AGY from acid in the stomach and intestine. We are testing AGY to see how well it can bind with gluten an individual may be accidentally eating. We hope that by binding to gluten, the gluten will be blocked from reaching the walls of the intestine and causing damage and symptoms. If people with CD are able to take AGY capsules and safely eat a diet where some foods may be contaminated with gluten, their quality of life would be improved.

This product is currently investigational, meaning that Health Canada has not approved its use, outside of a study. It has been approved for use in this study. We aim to enroll 149 people into the study.

MEDICAL DISCLAIMER: The AGY Celiac app is not intended for diagnosis or screening. Users should be aware that the AGY Celiac app is an information management service and is not intended to be a substitute for the advice of a healthcare professional. Individuals should always consult their doctor or other qualified healthcare professional with any questions they may have regarding a medical condition. You should never disregard professional medical advice or delay in seeking it because of information transmitted to or contained in this app.

最新版本1.0.0更新日誌

Last updated on 2021年01月28日

Minor bug fixes and improvements. Install or update to the newest version to check it out!

翻譯中...

更多應用信息

最新版本

請求 AGY Celiac 更新 1.0.0

系統要求

4.1 and up

Available on

AGY Celiac 來源 Google Play

更多

AGY Celiac 螢幕截圖

評論載入中...
語言
搜索中...
訂閱APKPure
第一時間獲取熱門安卓遊戲應用的首發體驗,最新資訊和玩法教程。
不,謝謝
訂閱
訂閱成功!
您已訂閱APKPure。
訂閱APKPure
第一時間獲取熱門安卓遊戲應用的首發體驗,最新資訊和玩法教程。
不,謝謝
訂閱
成功!
您已訂閱我們的郵件通知。